Resource Management’s GSK GSK Stock Holding History

Resource Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.33M	Buy	24,130 +12	+0%	+$624	0.14%	53
2021 Q3	$1.15M	Buy	24,118 +12	+0%	+$603	0.13%	59
2021 Q2	$1.2M	Sell	24,106 -698	-3%	-$33.5K	0.14%	57
2021 Q1	$1.11M	Sell	24,804 -6,011	-20%	-$273K	0.13%	56
2020 Q4	$1.42M	Sell	30,815 -1,382	-4%	-$63.5K	0.19%	43
2020 Q3	$1.51M	Sell	32,197 -278	-0.9%	-$13.9K	0.25%	37
2020 Q2	$1.66M	Buy	32,475 +14,187	+78%	+$728K	0.29%	32
2020 Q1	$866K	Buy	18,288 +11,114	+155%	+$593K	0.18%	48
2019 Q4	$421K	Hold	7,174	–	–	0.07%	96
2019 Q3	$382K	Sell	7,174 -76	-1%	-$3.91K	0.07%	97
2019 Q2	$363K	Buy	7,250 +1,600	+28%	+$80.3K	0.06%	100
2019 Q1	$295K	Sell	5,650 -76	-1%	-$3.8K	0.05%	110
2018 Q4	$273K	Sell	5,726 -76	-1%	-$3.74K	0.06%	103
2018 Q3	$291K	Sell	5,802 -20	-0.3%	-$1.02K	0.05%	113
2018 Q2	$293K	Buy	5,822 +1,000	+21%	+$50.4K	0.06%	100
2018 Q1	$236K	Sell	4,822 -2,027	-30%	-$94.4K	0.05%	114
2017 Q4	$312K	Buy	+6,849	New	+$316K	0.06%	96

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Resource Management's GSK Position: Q4 2021 in Review

Resource Management increased its GSK (GSK) stake by 0.05% in Q4 2021, buying an estimated $624 and bringing the position to 24,130 shares worth $1.33M. The position accounts for 0.14% of the portfolio, ranked #53.

Resource Management first reported a position in GSK in Q4 2017 and has held it in 17 quarters since. The position peaked at $1.66M in Q2 2020. 920 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

Resource Management held 24,130 shares of GSK worth $1.33M as of Q4 2021.
Resource Management bought 12 GSK shares in Q4 2021, an estimated $624.
GSK made up 0.14% of Resource Management's portfolio in Q4 2021, its #53 holding.
Resource Management first reported a position in GSK in Q4 2017 and has held it in 17 quarters since.
Resource Management's GSK position peaked at $1.66M in Q2 2020.
920 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Resource Management's 13F filing for Q4 2021, filed 14 Feb 2022.